Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Schütte, Mark ^a   Thullier, Philippe ^b   Pelat, Thibaut ^b   Wezler, Xenia ^a   Rosenstock, Philip ^a,e   Hinz, Dominik ^a,f   Kirsch, Martina Inga ^a,g   Hansenberg, Mike ^c   Frank, Ronald ^d   Schirrmann, Thomas ^a   Gunzer, Matthias ^c   Hust, Michael ^a   Dübel, Stefan ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b CENTRE DE RECHERCHES   (France)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; GLYCOSIDASE; PROTEIN ASPF16; PROTEIN ASPF9; PROTEIN CRF1; PROTEIN CRF2; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; COMPLEMENTARY DNA; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIUM DETECTION; CANDIDA ALBICANS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; FUNGUS HYPHAE; FUNGUS SPORE; GENE LIBRARY; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; RNA SPLICING; SEQUENCE HOMOLOGY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BASE SEQUENCE; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FUNGAL PROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RNA SPLICING; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 68949150896     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006625     Document Type: Article

References (62)

1. Latgé JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12: 310-50.
2. Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5: 609-22.
3. Marr KA, Patterson T, Denning D (2002) Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 16: 875-94.
4. Latgé JP (2001) The pathobiology of Aspergillus fumigatus. Trends Microbiol 9: 382-9.
5. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, et al. (2009) Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47: 129-33. doi:10.1128/ JCM.00506-08.
6. Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26: 781-803.
7. Rüping MJGT, Vehreschild JJ, Cornely OA (2008) Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68: 1941-62.
8. Cordonnier C, Botterel F, Maury S, Pautas C, Kuentz M, et al. (2005) New findings and key questions in hematopoietic stem cell transplantation. Med Mycol 43 Suppl 1: S243-6.
9. Denning DW (2003) Echinocandin antifungal drugs. Lancet 362: 1142-51.
10. Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, et al. (2006) Multiazole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 28: 450-3.
11. Sanglard D (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5: 379-85.
12. Ikemoto H (2000) Medical treatment of pulmonary aspergilloma. Intern Med 39: 191-2.
13. Nadkarni T, Goel A (2005) Aspergilloma of the brain: an overview. J Postgrad Med 51 Suppl 1: S37-41.
14. Kanu A, Patel K (2008) Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 43: 1249-51.
15. Nepomuceno IB, Esrig S, Moss RB (1999) Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 115: 364-70.
16. Skov M, Høiby N, Koch C (2002) Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 57: 723-8.
17. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, et al. (2004) Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 42: 2733-41.
18. Florent M, Katsahian S, Vekhoff A, Levy V, Rio B, et al. (2006) Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 193: 741-7.
19. Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67: 1567-601.
20. Hidalgo A, Parody R, Martino R, Sánchez F, Franquet T, et al. (in press) Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis. Eur J Radiol.
21. Diederich S, Scadeng M, Dennis C, Stewart S, Flower CD (1998) Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings. Eur Radiol 8: 306-12.
22. Arroyo J, Sarfati J, Baixench MT, Ragni E, Guillén M, et al. (2007) The GPI-anchored Gas and Crh families are fungal antigens. Yeast 24: 289-96.
23. Bozza S, Gaziano R, Lipford GB, Montagnoli C, Bacci A, et al. (2002) Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 4: 1281-90.
24. Denikus N, Orfaniotou F, Wulf G, Lehmann PF, Monod M, et al. (2005) Fungal antigens expressed during invasive aspergillosis. Infect Immun 73: 4704-13.
25. Crameri R, Kodzius R, Konthur Z, Lehrach H, Blaser K, et al. (2001) Tapping allergen repertoires by advanced cloning technologies. Int Arch Allergy Immunol 124: 43-7.
26. Kodzius R, Rhyner C, Konthur Z, Buczek D, Lehrach H, et al. (2003) Rapid identification of allergen-encoding cDNA clones by phage display and high-density arrays. Comb Chem High Throughput Screen 6: 147-54.
27. Banerjee B, Kurup VP, Greenberger PA, Johnson BD, Fink JN (2001) Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA). Clin Exp Allergy 31: 761-70.
28. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA (2005) Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol 139: 257-67.
29. Bowyer P, Denning DW (2007) Genomic analysis of allergen genes in Aspergillus spp: the relevance of genomics to everyday research. Med Mycol 45: 17-26.
30. Mabey JE, Anderson MJ, Giles PF, Miller CJ, Attwood TK, et al. (2004) CADRE: the Central Aspergillus Data REpository. Nucleic Acids Res 32: D401-405.
31. Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, et al. (2005) Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438: 1151-6.
32. Staib F, Mishra SK, Rajendran C, Voigt R, Steffen J, et al. (1980) A notable Aspergillus from a mortal aspergilloma of the lung. New aspects of the epidemiology, serodiagnosis and taxonomy of Aspergillus fumigatus. Zentralbl Bakteriol A 247: 530-6.
33. Løset GA, Løbersli I, Kavlie A, Stacy JE, Borgen T, et al. (2005) Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire. J Immunol Methods 299: 47-62.
34. Kirsch M, Hülseweh B, Nacke C, Rülker T, Schirrmann T, et al. (2008) Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 8: 66.
35. Hust M, Toleikis L, Dübel S (2007) Antibody phage display. Handbook of therapeutic antibodies. Weinheim: Wiley-VCH.
36. Retter I, Althaus HH, Münch R, Müller W (2005) VBASE2, an integrative V gene database. Nucleic Acids Res 33: D671-4.
37. Pelat T, Bedouelle H, Rees AR, Crennell SJ, Lefranc M, et al. (2008) Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol 384: 1400-7.
38. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-95.
39. Hust M, Dübel S, Schirrmann T (2007) Selection of recombinant antibodies from antibody gene libraries. Methods Mol Biol 408: 243-55.
40. Hust M, Dübel S (2004) Mating antibody phage display with proteomics. Trends Biotechnol 22: 8-14.
41. Thie H, Meyer T, Schirrmann T, Hust M, Dübel S (2008) Phage display derived therapeutic antibodies. Curr Pharm Biotechnol 9: 439-46.
42. Winter G, Milstein C (1991) Man-made antibodies. Nature 349: 293-9.
43. Hoogenboom HR (2005) Selecting and screening recombinant antibody libraries. Nat Biotechnol 23: 1105-16.
44. Lundquist R, Nielsen LK, Jafarshad A, Soesoe D, Christensen LH, et al. (2006) Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties. Infect Immun 74: 3222-31.
45. Bruneau JM, Magnin T, Tagat E, Legrand R, Bernard M, et al. (2001) Proteome analysis of Aspergillus fumigatus identifies glycosylphosphatidylinositol-anchored proteins associated to the cell wall biosynthesis. Electrophoresis 22: 2812-23.
46. Mouyna I, Fontaine T, Vai M, Monod M, Fonzi WA, et al. (2000) Glycosylphosphatidylinositol-anchored glucanosyltransferases play an active role in the biosynthesis of the fungal cell wall. J Biol Chem 275: 14882-9.
47. Fenelon LE, Hamilton AJ, Figueroa JI, Bartholomew MA, Allen MH, et al. (1999) Production of specific monoclonal antibodies to Aspergillus species and their use in immunohistochemical identification of aspergillosis. J Clin Microbiol 37: 1221-3.
48. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, et al. (1994) Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13: 3245-60.
49. Krauss J, Arndt MAE, Martin ACR, Liu H, Rybak SM (2003) Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment. Protein Eng 16: 753-9.
50. Doná MG, Giorgi C, Accardi L (2007) Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis. BMC Cancer 7: 25.
51. Chowdhury PS, Viner JL, Beers R, Pastan I (1998) Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc Natl Acad Sci U S A 95: 669-74.
52. Slobbe L, Polinder S, Doorduijn JK, Lugtenburg PJ, el Barzouhi A, et al. (2008) Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin Infect Dis 47: 1507-12.
53. Van Campenhout H, Marbaix S, Derde M, Annemans L (2008) Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results. Clin Drug Investig 28: 509-21.
54. Behnsen J, Narang P, Hasenberg M, Gunzer F, Bilitewski U, et al. (2007) Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans. PLoS Pathog 3: e13.
55. Cloutier SM, Couty S, Terskikh A, Marguerat L, Crivelli V, et al. (2000) Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Mol Immunol 37: 1067-77.
56. Frank R (1992) Spot-Synthesis: An easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48: 9217-9232.
57. Frank R (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports - principles and applications. J Immunol Methods 267: 13-26.
58. Frank R, Dübel S (2005) Analysis of protein interactions with immobilized peptide arrays synthesized on membrane supports. Protein-Protein Interactions, A Molecular Cloning Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. pp 591-608.
59. Sambrook J, Russell D (2001) Molecular cloning: a laboratory manual. 3. ed. New York: Cold Spring Harbor Laboratory Press.
60. Laffly E, Danjou L, Condemine F, Vidal D, Drouet E, et al. (2005) Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob Agents Chemother 49: 3414-20.
61. Pelat T, Hust M, Laffly E, Condemine F, Bottex C, et al. (2007) High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 51: 2758-64.
62. Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, et al. (2005) A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202: 597-606.